Multiple Myeloma

FDA Approves first CAR T-cell therapy in patients with multiple myeloma.

Darzalex is effective myeloma treatment in several settings - most recently for transplant ineligible patients.

Ask The Expert about stem cell transplant and CAR T cell therapy during the COVID pandemic.

Xpovio treatment of Multiple Myeloma receives FDA approval - combination appears superior to Vd with less neuropathy.

Talquetamab is a CPRC5DxCD3 Bispecific Antibody being developed for the treatment of myeloma - early results promising.

Pfizer PF-06863135, an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody.

BCMAxCD3 Bispecific Teclistamab show preliminary effectiveness in patients with advanced Multiple Myeloma